Hypercalcemia may indicate cancer
the ONA take:
According to a new study published in the British Journal of Cancer, hypercalcemia in men was linked with an increased risk for developing cancer within 1 year of detecting elevated blood levels of calcium.
For the study, researchers from the Centre for Academic Primary Care at the University of Bristol in Bristol, United Kingdom, sought to determine whether elevated levels of calcium in the blood could be utilized as an early screening method for the diagnosis of cancer.
The researchers identified 54,000 patients in an electronic database and analyzed their medical records to look for patients with a history of hypercalcemia that were later diagnosed with cancer. They found that men with a calcium level of 2.6 to 2.8 mmol/L (normal calcium level is 2.1 to 2.5 mmol/L) had an 11.5% increased risk of a cancer diagnosis within 1 year of identifying the elevated calcium level. Men with a calcium level greater than 2.8 mmol/L had a 28% increased risk.
Women had an increased risk for a cancer diagnosis as well, but the effect was smaller than men. Furthermore, hypercalcemiia was associated with bowel, breast, leukemia, lung, myeloma, and prostate cancer.
Hypercalcemia in men was linked with an increased risk for developing cancer.
Calcium in the blood could provide an early warning of certain cancers, especially in men, research has shown. Even slightly raised blood levels of calcium in men was associated with an increased risk of cancer diagnosis within one year.
The discovery, reported in the British Journal of Cancer, raises the prospect of a simple blood test to aid the early detection of cancer in high risk patients. Hypercalcaemia - a higher than normal calcium reading - was associated with a wide range of cancers, chiefly lung, prostate, breast, bowel, and those affecting the blood such as leukaemia and myeloma.
While the condition was already known to occur in up to a fifth of cancer patients, this is the first time it has been shown to pre-date diagnosis.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|